The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intra-patient comparison of urinary radioactivity after 18F-piflufolastat and 18F-flotufolastat PET in men with low PSA biochemical recurrence of prostate cancer who have had radical prostatectomy.
 
Jack Andrews
Consulting or Advisory Role - Bayer; Provepharm
 
David Josephson
Employment - Tower Urology
Leadership - ASC Venture Beverly Hills
Research Funding - Blue Earth Diagnostics; Lantheus Medical Imaging
 
Daniel Saltzstein
No Relationships to Disclose
 
Andrei Purysko
Research Funding - Lantheus Medical Imaging
 
Neal Shore
Employment - GenesisCare
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Peerview; Pfizer; Photocure; PlatformQ Health; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow
 
Benjamin Gartrell
Honoraria - Janssen
Consulting or Advisory Role - Bayer; Janssen; Pfizer
Speakers' Bureau - Bristol Myers Squibb Foundation
 
Ram Pathak
Consulting or Advisory Role - Ambu; profound
Research Funding - Blue Earth Diagnostics; Samaritan Biologics
 
Phillip Kuo
Honoraria - Attralus; Blue Earth Diagnostics; Chimerix; dGenThera; Fusion Pharmaceuticals; GE Healthcare; Invicro; Life Molecular Imaging; Lilly; Navidea; Novartis; Radionetics; Telix Pharmaceuticals; United Imaging
Consulting or Advisory Role - Attralus; Blue Earth Diagnostics; Chimerix; dGenThera; Fusion Pharmaceuticals; GE Healthcare; Invicro; Life Molecular Imaging; Lilly; Navidea; Novartis; Radionetics; Telix Pharmaceuticals; United Imaging
Speakers' Bureau - GE Healthcare; Lilly; Novartis
Research Funding - Blue Earth Diagnostics; GE Healthcare
Travel, Accommodations, Expenses - Blue Earth Diagnostics; GE Healthcare; Invicro; Lilly; Novartis; Telix Pharmaceuticals
 
James Sykes
Employment - Blue Earth Diagnostics
 
Phillip Davis
Employment - Blue Earth Diagnostics
 
Brian Helfand
Consulting or Advisory Role - Ambry Genetics; Blue Earth Diagnostics; Exact Sciences; GoPath Laboratories; Procept Biorobotics
Speakers' Bureau - Blue Earth Diagnostics; Exact Sciences; Procept Biorobotics